Aurinia Pharmaceuticals Inc Stock Forecast
Aurinia Pharmaceuticals Inc stock upgraded to Hold/Accumulate.
(Updated on Apr 24, 2024)
The Aurinia Pharmaceuticals Inc stock price fell by -1.18% on the last day (Wednesday, 24th Apr 2024) from $5.09 to $5.03. During the last trading day the stock fluctuated 3.20% from a day low at $5.00 to a day high of $5.16. The price has been going up and down for this period, and there has been a 0.8% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -146 thousand shares and in total, 758 thousand shares were bought and sold for approximately $3.81 million.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -37.49% during the next 3 months and, with a 90% probability hold a price between $2.43 and $3.50 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
AUPH Signals & Forecast
A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 4.57%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Aurinia Pharmaceuticals Inc stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $5.11. On a fall, the stock will find some support from the short-term average at $4.98. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Aurinia Pharmaceuticals Inc stock
Aurinia Pharmaceuticals Inc finds support from accumulated volume at $5.01 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.160 (3.20%) between high and low. For the last week, the stock has had daily average volatility of 3.77%.
Our recommended stop-loss: $4.80 (-4.60%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 4 days ago.)
Trading Expectations (AUPH) For The Upcoming Trading Day Of Thursday 25th
For the upcoming trading day on Thursday, 25th we expect Aurinia Pharmaceuticals Inc to open at $5.06, and during the day (based on 14 day Average True Range), to move between $4.84 and $5.22, which gives a possible trading interval of +/-$0.195 (+/-3.88%) up or down from last closing price. If Aurinia Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 7.75% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $5.01 (0.40%) than the resistance at $5.85 (16.30%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Aurinia Pharmaceuticals Inc will release earnings BMO on Thursday, May 02, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.170. We will update the financials statements for Aurinia Pharmaceuticals Inc, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 9.16% in the first trading day after earnings release.
Is Aurinia Pharmaceuticals Inc stock A Buy?
Aurinia Pharmaceuticals Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.
Current score: -0.419 Hold/Accumulate Upgraded
Predicted Opening Price for Aurinia Pharmaceuticals Inc of Thursday, April 25, 2024
| Fair opening price April 25, 2024 | Current price |
|---|---|
| $5.06 ( 0.663%) | $5.03 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for AUPH
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 5.22 | 3.84 % | |
| R2 | 5.16 | 2.63 % | ||
| R1 | 5.12 | 1.88 % | ||
| Current price: | 5.03 | |||
| Support | S1 | 5.00 | -0.552 % | |
| S2 | 4.96 | -1.30 % | ||
| S3 | 4.90 | -2.52 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 6.02 | 19.68 % | |
| R2 | 6.00 | 19.28 % | ||
| R1 | 5.85 | 16.30 % | ||
| Current price | 5.03 | |||
| Support | S1 | 5.01 | -0.398% | |
| S2 | 5.00 | -0.596% | ||
| S3 | 4.99 | -0.795% |
FAQ
Click here for our free guide on how to buy Aurinia Pharmaceuticals Inc Stock.
